Evidence map›Paper›PMID 39812061›Full record

ArticleCombinatorial chemistry & high throughput screening2025

Betanin Mitigates Inflammation and Ankle Joint Damage by Inhibiting the MAPK/NF-κB Pathway in Arthritis Triggered by Type II Collagen in Rats.

Yongxiang He, Shaik Althaf Hussain, Wenjie Dai

Abstract read
PubMed Publisher
In one paragraph

Article in Combinatorial chemistry & high throughput screening, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Betanin fromBiomedicines · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yongxiang HeDepartment of Orthopedics, Yan'an People's Hospital, Yan'an, 719000, China.
Shaik Althaf HussainDepartment of Zoology, College of Science, King Saud University, P.O. Box - 2454, Riyadh-11451, Saudi Arabia.
Wenjie DaiDepartment of Orthopedics, Hanzhong People's Hospital, Hanzhong, 723000, China.

Funding

King Saud University, Riyadh, Saudi Arabia RSP2025R371
6 · The paper itself

Abstract

backgroundRheumatoid Arthritis (RA), a chronic inflammatory autoimmune illness, is characterized by synovitis, progressive joint damage, and bone erosion. Even though the potent drugs available contain biologics, several patients fail to react to them or cause hostile effects.

objectivesBetanin (BTN), the betacyanin present in the red beetroot, has antioxidant, antiinflammatory, and apoptotic properties. In this study, we assessed the anti-inflammatory and apoptotic effect of BTN on collagen-induced arthritis (CIA). MATERIALS AND

methodsThe rats were arbitrarily separated into four sets: Normal, CIA, CIA+BTN (25 mg/kg bw), and CIA+BTN (50 mg/kg bw). The hematological, biochemical markers, cytokines, inflammatory enzymes, histopathology of the ankle joint, and protein expression of inflammatory and apoptotic proteins were studied.

resultsInflammatory enzymes, histopathological variations, cytokines generation, and joint inflammation were strongly alleviated, and apoptosis was augmented by BTN in a concentrationdependent manner. Bcl-2 and MAPK/NF-κB proteins were reduced, while the caspase-3, caspase- 9, and Bax were intensified. The anti-rheumatic action of BTN was correlated to the attenuation of the MAPK/NF-κB pathway, which suppresses cytokine production, inflammation, and reduced cartilage impairments.

conclusionThese outcomes recommend that BTN can be employed as a strong healing alternative for RA management.

Indexed as

Ankle JointArthritis, ExperimentalBetacyaninsInflammationMitogen-Activated Protein KinasesNF-kappa BAnimalsApoptosisCollagen Type IICytokinesDose-Response Relationship, DrugMaleRatsRats, WistarBetacyaninsbetaninCollagen Type IICytokinesMitogen-Activated Protein KinasesNF-kappa BapoptosisBetanincollagen-induced arthritiscytokinesinflammatory enzymes.MAPK/ NF-κB

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.